A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Simple Search

You could also try: wheel (17), pedals (5)

Regorafenib

Description
Chemotherapy Protocol Gastro-Intestinal Stromal Tumour Regorafenib Regimen • GIST – Regorafenib Indication • Regorafenib is recommended for histologically confirmed metastatic or unresectable gastronintestinal
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/Regorafenib.pdf

Regorafenib

Description
Chemotherapy Protocol Hepatocellular Cancer Regorafenib Regimen • Hepatocellular – Regorafenib Indication • Regorafenib is recommended as an option for treating advanced unresectable hepatocellular carcinoma
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Hepatobiliary/Regorafenib.pdf

Alternatives to HRT for symptoms of the menopause - patient information

Description
This factsheet contains some non-hormonal alternatives and lifestyle changes you can try to help manage your menopausal symptoms.
Url
/Media/UHS-website-2019/Patientinformation/Womenshealth/Alternatives-to-HRT-for-symptoms-of-the-menopause-3081-PIL.pdf

Steroid therapy for brain tumours - patient information

Description
Information about steroid therapy for brain tumours.
Url
/Media/UHS-website-2019/Patientinformation/Brain-and-spine/Steroid-therapy-for-brain-tumours-494-PIL.pdf

Everolimus-Exemestane

Description
Regimen Chemotherapy Protocol BREAST CANCER EVEROLIMUS and EXEMESTANE • Breast Cancer – Everolimus-Exemestane Indication • The first or second line treatment of post
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Everolimus-Exemestane.pdf

Impaired glucose tolerance in cystic fibrosis - patient information

Description
This factsheet is about impaired glucose tolerance (IGT) in people with cystic fibrosis (CF).
Url
/Media/UHS-website-2019/Patientinformation/Medicinestherapiesandanaesthetics/Impaired-glucose-tolerance-in-cystic-fibrosis-2636-PIL.pdf

Bevacizumab (15mgkg)

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER BEVACIZUMAB (15) This protocol may require funding Regimen Ovary-Bevacizumab (15) Indication Recurrent platinum sensitive ovarian, peritoneal
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Bevacizumab15mgkg.pdf

Irinotecan Ver 1.2

Description
Chemotherapy Protocol COLORECTAL CANCER Regimen IRINOTECAN Colorectal Cancer– Irinotecan Indication Second line treatment of advanced colorectal cancer WHO performance status 0
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/IrinotecanVer12.pdf

Capecitabine-Mitomycin

Description
Chemotherapy Protocol COLORECTAL CANCER CAPECITABINE-MITOMYCIN Regimen • Colorectal Cancer – Capecitabine-Mitomycin Indication • Second / third line therapy of metastatic/advanced colorectal cancer
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Capecitabine-Mitomycin.pdf

Procedure for adult weight

Description
NIHR Southampton Biomedical Research Centre The NIHR Southampton Biomedical Research Centre (BRC) has a tight quality assurance system for the writing
Url
/Media/Southampton-Clinical-Research/Procedures/BRCProcedures/Procedure-for-adult-weight.pdf
291 to 300 of 1000
Previous … 28 29 30 31 32 … Next